Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phacodyne is a lutein-based intraocular vital dye utilized in ophthalmic surgery to enhance the visualization of intraocular membranes. It is primarily composed of lutein, a natural carotenoid, which provides a yellow-orange stain to target structures such as the anterior lens capsule during cataract surgery and the Descemet membrane during endothelial keratoplasty. Developed as a biocompatible alternative to synthetic dyes like Trypan Blue (VisionBlue) and Indocyanine Green, Phacodyne facilitates precise surgical maneuvers such as continuous circular capsulorhexis (CCC) by providing clear contrast. Its mechanism of action is physical, involving the coating and staining of basement membranes without chemical interaction or toxicity to the corneal endothelium or other sensitive intraocular tissues.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Phacodyne.